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A B S T R A C T
Group B streptococcus (GBS) is a commonly recognized cause of sepsis and meningitis in neonatal and
young infants. Invasive GBS infection is classiﬁed into early onset GBS disease (EOD, day 0–6), late onset
GBS disease (LOD, day 7–89) and ultra late onset GBS disease (ULOD, after 3 months of age). ULOD is
uncommon and recurrence is especially rare. We present the ﬁrst recurrent case of ULOD GBS sepsis in 3-
year-old girl with a past medical history of hydrops fetalis and thoracic congenital lymphatic dysplasia.
The ﬁrst episode presented as sepsis at 2 years 8 months of age. The second episode occurred as sepsis
with encephalopathy at 3 years 1 months of age. During each episode, the patient was treated using
intravenous antimicrobials and her condition improved. Serotype examination was not performed in the
ﬁrst episode, but GBS type V was serotyped in the second episode. ULOD over 1 year of age is quite rare
and may recur.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Group B streptococcus (GBS) is a commonly recognized cause of
sepsis and meningitis in neonatal and young infants. Invasive GBS
infection is classiﬁed into early onset GBS disease (EOD, day 0–6),
late onset GBS disease (LOD, day 7–89) and ultra late onset GBS
disease (ULOD, after 3 months of age) [1,2]. The characteristics of
EOD and LOD have been well documented, but little is known
about ULOD. Several cases of ULOD have been reported [2], but
ULOD after 1 year of age is rare and recurrent case is especially rare.
We report the ﬁrst case of recurrent invasive ultra late onset GBS
infection.
Case report
The patient was the ﬁrst female child of healthy unrelated
parents. She was diagnosed with hydrops fetalis and drainage of
pleural effusions was performed before birth. At 30 weeks and
5 days gestation, the patient was born via caesarian section
because of an increase in pleural effusion. Her birth weight was* Corresponding author at: Department of Pediatrics, Keio University School of
Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
E-mail address: m-shinjo@z2.keio.jp (M. Shinjoh).
http://dx.doi.org/10.1016/j.idcr.2016.11.007
2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article un2325 g, but the estimated body weight was considered to be about
1200 g because of edema. The patient was intubated and general
care was provided in the NICU department. She was diagnosed
with thoracic congenital lymphatic dysplasia using scintigraphy.
She was treated using octeotides, diuretics and dexamethasone for
two months and was eventually discharged at one year of age with
home oxygen therapy. Maternal GBS colonization was negative.
During NICU admission, GBS strains were never isolated from any
cultures. There was no history of bacteremia nor seizures. She had
no other signiﬁcant past medical history except for a moderate
delay of developmental milestones including walking at 2 years
and 2 months of age, and still unable to speak meaningful words at
3 years of age.
At 2 years 8 months of age, the patient was admitted to a
hospital with a history of high-grade fever (39.3 C) and seizures.
Laboratory studies revealed a total WBC count of 22600/mm3 with
76% neutrophils and 19% lymphocytes, and a C-reactive protein
(CRP) result of 0.05 mg/dL. She was treated with intravenous
sulbactam/ampicillin with the diagnosis of suspected bacteremia.
Within 24 h her fever began to decrease and her mental status
improved. Twelve hours after admission, blood culture was
growing GBS. CRP increased to 7.33 mg/dL in 12 h. Nasal culture
did not reveal GBS. She was discharged after 10 days of intravenous
antimicrobial therapy.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1 month of age, she was admitted to a hospital for fever up to 40 C.
About two hours after admission, she had seizures. The con-
vulsions were generalized tonic-clonic seizures, which were
controlled with repeated doses of intravenous diazepam and
midazolam along with supportive measures. Laboratory studies
revealed a serum total WBC count of 9400/mm3 with 77%
neutrophils and 17% lymphocytes, CRP 0.14 mg/dL and normal
CSF parameters. The patient was empirically started on intrave-
nous ampicillin and ceftriaxone. On the second day after
admission, she was still febrile (40 C) and toxic, with tachycardia
including a heart rate of 180/min. Her neurological status did not
improve. Laboratory studies revealed a serum total WBC count of
14200/mm3, AST 545 IU/L, ALT 241 IU/L, CRP 17.76 mg/dL and
procalcitonin >100 mg/L. The electroencephalogram showed dif-
fuse slow waves.
The patient was transferred to a tertiary hospital with a
diagnosis of sepsis and encephalopathy. Antimicrobials were
continued. Ultrasound revealed no signs of endocarditis. Neither
intubation nor therapeutic hypothermia was performed. GBS was
isolated in the blood culture, but CSF and urine cultures were
sterile, and nasal and rectal cultures did not reveal GBS. MRI of the
head revealed clinically mild encephalopathy with a reversible
splenial lesion; MERS. After isolation of GBS from the blood,
antimicrobials were deescalated to ampicillin alone for 14 days.
The GBS isolate was serotyped as GBS type V. The patient was
discharged on the 40th hospital day with mild neurologic sequelae,
including brain atrophy. She also showed signs of temporal
regression of motor function, which improved over time.
Quantitative immunoglobulin (Ig) and complement (C) values
were normal (IgG 763 mg/dL, IgA 51 mg/dL, IgM 161 mg/dL, C3
71.0 mg/dL, C4 17.0 mg/dL, CH50 15.9 IU/mL). Neutrophil oxidative
burst test results were normal (97%). IgG subclasses were also
normal (IgG1 785.0 (65.9%), IgG2 324.0 (27.2%), IgG3 17.2 (1.44%),
IgG4 65.0 (5.46%)). Neutrophil count was normal since birth, and no
family members were compromised hosts. HIV testing was
negative.
Discussion
We made two important clinical observations in this case. First,
recurrent ULOD GBS infection is extremely rare among children
over 1 year of age. To our knowledge, this is the ﬁrst report of
recurrent invasive GBS infection in ULOD. Second, ULOD GBS
infection over 1 year of age, compared to infection before 1 year of
age can be associated with underlying conditions.Table 1
Characteristics of invasive GBS disease among children aged 1 through 14 years.
Patient Reference
number
Age
(y,m)
Gender Gestational age Clinical Manifestatio
1 [4] 1y4m Male Term Bacteremia 
2 [4] 1y6m NR Term Bacteremia 
3 [4] 1y9m Female Term Endocarditis 
4 [4] 3y Male Term Bacteremia 
5 [4] 12y Female NR Ventriculostomy-ass
infection, meningiti
6 [4]. 14y Female NR VP shunt infection, 
7 [5] 1y5m NR 34w3d Bacteremia 
8 [5] 3y8m NR 37w2d Bacteremia 
9 [6] 5y Male NR Meningitis 
10 [7] 9y Female NR Meningitis 
11 Our patient 2y8m Female 30w5d Sepsis 
12 Our patient 3y1m Female 30w5d Sepsis, encephalopa
NT, not tested; NR, not reported; VP, ventriculoperitoneal.A 2008 report from the USA identiﬁed 90 cases of invasive GBS
disease in children aged 1 through 14 years from 1999 to 2005, but
the details of clinical data for each case have not been reported [3].
The ULOD incidence rate in Japan was unknown, but the estimated
incidence of invasive GBS disease in the United States is 0.22 per
100,000 population in individuals aged 1 through 14 years [3]. Ten
other cases of ULOD among children aged 1 through 14 years have
been reported [4–7]. Demographics and clinical data for each case
are summarized in Table 1. Three patients were male, 6 were
female (including our patient), and for 3, the gender was not
reported. Only our case had recurrent ULOD infection. In our
patient, both infections presented as sepsis: the ﬁrst infection as
sepsis and the second infection as sepsis with encephalopathy [8].
Although relapse or recurrence of neonatal and infantile GBS
infection has been described, recurrent invasive GBS infection in
ULOD has not been reported. Hypotheses regarding the cause of
recurrence in EOD and LOD have been suggested by many authors.
The combined effect of immature immune mechanisms and
persistent mucosal colonization may permit reinvasion from the
mucosal surface and the establishment of recurrent systemic GBS
infection [9,10]. In our patient, GBS serotype V was found in the
second infection but we did not examine the serotype in the initial
infection. Recurrent GBS infection does not necessarily imply
relapse with the same GBS serotype.
The deﬁnition of ULOD is somewhat ambiguous. ULOD is
typically deﬁned with a lower age threshold (>90 days), but its
upper age limit is either variably deﬁned or undeﬁned. We chose to
apply the term to children aged over 90 days to 14 years as Phares
et al. deﬁned [3]. The term “ULOD” is an extension of the terms of
“EOD” and “LOD” neonatal GBS. Although the term “ULOD” may be
reasonable to refer to sepsis that occurs in infants, it may be
inappropriate to apply to sepsis in older children and ULOD above
1 year of age may have different pathophysiology. Therefore we
believe that ULOD above 1 year of age should be conceptualized
separately as “childhood” or “pediatric” ULOD.
ULOD GBS infection over 1 year of age, compared to infection
before 1 year of age, appears to be associated with underlying
conditions. In our review, 66% (8/12) had at least 1 underlying
condition including neurologic disorders, hydrops fetalis with
lymphatic dysplasia, congenital ectodermal dysplasia with hyper
IgM globulinemia and congenital heart disease (Table 1). Three
patients had undergone surgery for cerebrospinal ﬂuid drainage,
ventriculo-peritoneal shunt and ventriculostomy. A previous study
showed that only 11% of children aged 90 days through 12 months
had an underlying condition (excluding preterm birth), but 44% of
children aged 1 through 14 years had at least 1 underlyingn Underlying Condition Outcome Serotype
None Alive NT
None Alive II
Congenital heart disease Alive Ia
None Alive III
ociated
s
AV malformation, intraventricular
hemorrhage
Death Ib/c
meningitis Arnold-Chiari malformation Alive NT
Cerebellar tumor Alive NT
Congenital ectodermal dysplasia,
hyper-IgM globulinemia
Alive NT
None Alive NT
Lumbar spina biﬁda, hydrocephalus with
VP shunt
Alive NT
Hydrops fetalis, lymphatic dysplasia Alive NT
thy Hydrops fetalis, lymphatic dysplasia Alive V
18 A. Hosoda et al. / IDCases 7 (2017) 16–18condition, including neurologic disorders, immunosuppressive
conditions, asthma, malignancy and renal disease [3]. Our review
also suggests that ULOD above 1 year of age is more likely to be
associated with underlying conditions. Our patient was born
preterm and had hydrops fetalis and lymphatic dysplasia. Lymphatic
dysplasia may be associated with insufﬁcient immunity. In a
previous report, the authors emphasized the importance of preterm
birth for ULOD GBS meningitis, where ULOD referred to infants less
than 1 year old [2]. Our ﬁndings including children aged 1 through
14 years did not suggest prematurity as a risk for ULOD.
Recurrent ULOD GBS infection is extremely rare among children
over 1 year of age. ULOD over 1 year of age is more likely to be
associated with underlying conditions compared to younger
children. In patients with underlying conditions, ULOD may occur
even over 1 year of age and can recur, therefore careful clinical
evaluation is necessary.
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